Related by context. All words. (Click for frequent words.) 70 CIN2 + 68 Adenomas 67 advanced adenoma 67 grade squamous intraepithelial 67 cervical carcinoma 67 nodal metastasis 67 cervical intraepithelial neoplasia 67 Alkaline Phosphatase 67 nephrogenic 67 thyroglobulin 67 Immunohistochemical staining 67 precursor lesions 66 gastric adenocarcinoma 66 grade cervical intraepithelial 66 neoplasias 65 pT2 65 PCa 65 lymphocytosis 65 urothelial carcinoma 65 bronchoalveolar lavage 65 Neisseria gonorrhoeae 65 pT3 65 HGPIN 65 Endometrial 65 leiomyomas 65 intravesical therapy 65 SLNB 65 intraepithelial neoplasia 65 NMIBC 65 immunohistochemical 65 HER2 overexpression 65 lupus anticoagulant 65 gastric carcinoma 65 serum prostate 65 cytologic 64 prostate cancer CaP 64 thyroid peroxidase 64 metastatic malignant 64 micrometastasis 64 transcranial Doppler ultrasound 64 colorectal carcinoma 64 mucinous 64 Inhibin B 64 cTnT 64 specific antigen PSA 64 ductal carcinomas 64 PSA nadir 64 ASCUS 64 mediastinitis 64 AST ALT 64 haematologic 64 papillary thyroid carcinoma 64 cytological 64 sonographically guided 64 Cystatin C 64 urine cytology 64 QTc prolongation 64 surgically resected 64 squamous cell carcinoma SCC 64 epithelial tumors 64 antibody titer 64 myelodysplastic myeloproliferative diseases 64 leiomyoma 64 histologic subtype 64 microsatellite instability 64 lymphovascular invasion 64 ultrasonographic 64 pelvic ultrasound 63 obstructive coronary artery 63 hematological parameters 63 ovarian carcinoma 63 transabdominal 63 coronary stenosis 63 syngeneic 63 Clusterin 63 inotropic 63 invasive carcinomas 63 guaiac 63 atypical hyperplasia 63 D dimer 63 transthoracic 63 metastatic lymph nodes 63 peritoneal carcinomatosis 63 HIV seropositive 63 HBsAg 63 transrectal ultrasound guided 63 rheumatoid factor 63 cervical lymph nodes 63 APTIMA HPV 63 completely resected 63 undetectable HBV DNA 63 immunoblotting 63 cervicitis 63 hepatocellular carcinomas 63 thymoma 63 clinicopathological features 63 biochemical relapse 63 Western blotting 63 papillary renal cell carcinoma 63 plasma pharmacokinetics 63 cTnI 63 normal karyotype 63 skeletal metastases 63 pleural fluid 63 invasive lobular carcinoma 63 endometrial carcinoma 63 aspartate aminotransferase AST 63 NPM1 mutation 63 hepatic cirrhosis 63 SGPT 63 multivariate Cox 63 TRUS 63 alpha1 antitrypsin deficiency 63 FluCAM arm 63 cytogenetic abnormalities 63 interleukin IL -# 63 immunostaining 62 chronic eosinophilic leukemia 62 microvessel density 62 lobular carcinoma 62 ara C 62 recurrent glioblastoma multiforme 62 colorectal adenoma 62 breast carcinomas 62 Histopathologic 62 TURBT 62 fetal aneuploidy 62 hepatorenal syndrome 62 tumorigenicity 62 fetal chromosomal 62 ductal lobular 62 T1c 62 situ LCIS 62 % CI #.#-#.# [005] 62 etiologic 62 pelvic lymphadenectomy 62 urodynamic 62 D Dimer 62 leukocyte adhesion 62 prostate carcinoma 62 immunohistochemical staining 62 paragangliomas 62 PAOD 62 relapsed MM 62 nonischemic 62 CIN3 62 aminotransferase 62 haematological 62 HCV antibody 62 cytogenic 62 Papillary 62 tryptase 62 pDC 62 glutamic acid decarboxylase 62 histological subtype 62 neoplastic 62 antiphospholipid antibodies 62 Pharmacokinetics PK 62 ADAMTS# 62 IgA antibody 62 EBRT 62 neoplasia CIN 62 Endothelial dysfunction 62 transurethral 62 transthoracic echocardiography 62 precancerous cervical lesions 62 Catheter Associated 62 serum aminotransferase levels 62 lymph node metastasis 62 histologically confirmed 62 renal scarring 62 cardiac troponin 62 radical prostatectomy RP 62 adrenalectomy 62 carcinoembryonic antigen 61 epithelial ovarian cancer 61 kidney allograft 61 colorectal adenocarcinoma 61 IgA antibodies 61 anti JCV antibodies 61 castrate resistant 61 Lymphocytic 61 Cathepsin B 61 Immunohistochemistry 61 CC genotype 61 LHRH receptor positive 61 duplex ultrasonography 61 latent tuberculosis TB 61 Radical prostatectomy 61 OGTT 61 endometrial hyperplasia 61 myeloproliferative diseases 61 surgically resectable 61 myelofibrosis polycythemia vera 61 malignant nodules 61 hematologic toxicity 61 Sezary syndrome 61 advanced neoplasia 61 ABCB1 61 IL 1ß 61 Annexin V 61 ultrasonographic examination 61 monocytic 61 adrenocortical cancer 61 radiotherapy RT 61 precancerous cervical 61 cell adhesion molecule 61 seminal vesicle invasion 61 nonmetastatic 61 hematopoietic cancers 61 SSc 61 beta estradiol 61 dysplastic lesions 61 transaminase 61 malignant polyps 61 cardiac troponin T 61 esophageal carcinoma 61 adenomatous polyps 61 M#V 61 genotypic resistance 61 proctitis 61 tumoral 61 Immunohistochemical 61 renal biopsy 61 Squamous 61 Hematologic 61 HER2 expression 61 CYT# potent vascular disrupting 61 p# antigen 61 systemic amyloidosis 61 abnormal cytology 61 ovarian malignancy 61 nodal metastases 61 LVNC 61 pericardial effusion 61 anti HBs 61 Ribavirin causes 61 Prostate specific antigen 61 isoenzyme 61 candidates Azedra TM 61 K ras mutations 61 serum ALT 61 cystoscopic 61 Lp PLA 2 61 GH deficiency 61 #ß 61 FDG PET imaging 61 hormone receptor negative 61 glucocorticoid induced 61 carcinomatosis 61 spiral computed tomography 61 hc2 61 TIMP 1 61 pelvic malignancies 61 human chorionic gonadotropin hCG 61 #ng/ml 61 invasive carcinoma 61 Bacteremia 61 transvaginal sonography 61 triiodothyronine 61 BRCA1 BRCA2 61 peritoneal fluid 61 axillary lymph node 61 abnormal pap smears 61 intestinal metaplasia 61 vaginal lesions 61 LPS induced 61 parathyroid 61 liver histology 61 inducible nitric oxide synthase 61 basal cell carcinoma BCC 61 immunohistochemical analysis 61 acute GvHD 61 LungAlert TM 61 prostate cancer PCa 61 bFGF 61 vulvar vaginal 61 BCG refractory carcinoma 61 mycosis fungoides 61 SUVmax 61 Cardiopulmonary bypass 61 ECG abnormalities 61 urothelial 61 urine albumin 61 serum biomarker 61 Estrogen Receptor 61 acid phosphatase PAP 61 methylenetetrahydrofolate reductase 61 Cervista HPV 61 protein tyrosine phosphatase 61 benign prostatic hyperplasia enlarged 61 seropositivity 61 HPV-#/# 61 CTAP# Capsules 61 pulmonary angiography 61 ADPKD 61 mesenteric 61 CTEPH 61 thymidine kinase 61 elevated ALT 61 rs# [004] 61 enzyme immunoassay EIA 61 endometrial adenocarcinoma 60 follicular thyroid cancer 60 tumor lysis syndrome 60 independent prognostic marker 60 immunohistochemistry IHC 60 Histologic 60 enzyme immunoassay 60 metastatic pancreatic 60 thyroid carcinoma 60 papillary carcinoma 60 thymectomy 60 hypophosphatemia 60 hypereosinophilic syndrome 60 metabolite concentrations 60 Prostate Specific Antigen 60 pancreatic prostate 60 pleomorphic 60 advanced adenomas 60 tracheal intubation 60 metastatic neuroendocrine tumors 60 invasive ductal 60 cervical adenocarcinoma 60 transgene expression 60 hepatic enzymes 60 bacteriuria 60 laparoscopically assisted 60 dehydroepiandrosterone sulfate 60 neuroendocrine carcinoma 60 latent tuberculosis infection 60 angiographically 60 HES CEL 60 pathologic diagnosis 60 erythropoietic 60 percutaneous vertebroplasty 60 locoregional 60 acute humoral rejection 60 Anti Bacterial Envelope 60 endometrioid 60 graft occlusion 60 gastrointestinal stromal tumors GISTs 60 bioavailable testosterone 60 RARP 60 BCG refractory 60 IgM antibodies 60 SGOT 60 endometrial biopsy 60 Dilated Cardiomyopathy 60 estrogen receptor ER 60 allogeneic HSCT 60 Serological 60 lobular carcinomas 60 thyroid nodules 60 FDG-PET/CT 60 #.#ng/ml 60 CD# CD# 60 intact parathyroid hormone 60 PCWP 60 Xanafide 60 histopathologic examination 60 hematopoietic progenitor cells 60 submucosal 60 RT PCR assay 60 c KIT 60 MDS MPD 60 K#R [002] 60 sporadic Creutzfeldt Jakob 60 cholangiocarcinoma 60 clinicopathologic 60 debulking surgery 60 GISTs 60 Abbott RealTime 60 adnexal mass 60 hyperplastic 60 BRAF V#E mutation 60 autologous SCT 60 penile cancers 60 FDG uptake 60 apolipoprotein B 60 p# biomarker 60 erythema nodosum 60 extracranial 60 tuberculin skin testing 60 iPTH 60 Histological 60 albumin excretion rate 60 atrophic gastritis 60 thyroid stimulating hormone TSH 60 TMPRSS2 ERG fusion 60 Accelerated Partial Breast Irradiation 60 adenomatous 60 total thyroidectomy 60 promoter methylation 60 BCR ABL mutations 60 intracerebral 60 serologic 60 sCJD 60 troponin T 60 metaplasia 60 calculated creatinine clearance 60 seronegative 60 cytoreductive nephrectomy 60 G CSFs 60 atrioventricular block 60 transesophageal echocardiography 60 pulmonary metastases 60 metastatic bladder 60 elevated transaminases 60 locoregional recurrence 60 renal cell carcinomas 60 hyperacute 60 effector function 60 thromboembolic disease 60 ELISpot 60 collagenous colitis 60 euthyroid 60 cause cardiac channelopathies 60 recurrent DVT 60 APTIMA R 60 BCL2 60 Secretase 60 choriocarcinoma 60 treat chronic sinusitis 60 tumor necrosis 60 TIMP 60 arteriography 60 PSADT 60 obstructive coronary 60 node metastases 60 ano genital warts 60 baseline LDH 60 erythrocyte sedimentation rate 60 postoperative complication 60 prolonged QT interval 60 hepatic enzyme 60 sonographic appearance 60 anemia neutropenia 60 Quantitation 60 urethral stricture 60 vapreotide acetate 60 cervical vulvar 60 hypothalamic pituitary 60 IFN γ 60 liver resection 60 IL#B 60 acetonide FA 60 FLT3 60 scintigraphic 60 histopathological 60 Prostatic 60 busulfan 60 mRNA expression 60 FOLFOX6 60 parasitemia 60 G6PD deficiency 60 HBeAg 60 neoplasm 60 ductal adenocarcinoma 60 GSTP1 60 Pneumocystis carinii pneumonia 60 Leydig cell 60 peripheral blood mononuclear 60 Cardiotoxicity 60 ductal breast cancer 60 maternal serum 60 rebleeding 60 metastatic gastric 60 detecting colorectal cancer 60 coronary arteriography 60 Haptoglobin 60 pharmacodynamic PD 60 Chlamydia trachomatis infection 60 transitional cell carcinoma 60 interferon γ 60 fibrin deposition 60 MLH1 60 TMPRSS2 ERG 60 underlying vasculopathy 60 Adenocarcinoma 60 neoadjuvant therapy 60 C. trachomatis 60 hamartomas 60 chlamydial 60 paraprotein 60 BRCA2 mutation carriers 60 KRAS oncogene 60 F FDG PET 60 Cervista 60 neovascularisation 60 uterine cervix 60 Mutational 60 Estradiol 60 pathologic examination 60 cat dander allergy 59 lysophosphatidic acid 59 Immunohistochemical analysis 59 renal allograft 59 ALT flares 59 lactate dehydrogenase LDH 59 preoperative PSA 59 haematopoietic 59 recurrent metastatic 59 acute myeloid 59 thromboemboli 59 psoriatic arthritis PsA 59 HCT# 59 myeloproliferative 59 Primary endpoints 59 neuroendocrine cancers 59 intravesical infusion therapy 59 Echocardiographic 59 Hurthle cell 59 LTBI 59 somatostatin analog 59 Hypotension 59 recurrent NSCLC 59 metachronous 59 needle aspiration 59 plasmacytoid 59 myeloproliferative neoplasms 59 extracapsular extension 59 MGd 59 immunochemical 59 cervical vaginal 59 isoprostane 59 enterococcal 59 core needle biopsy 59 activating mutation 59 bullous 59 tTG 59 immunochemical fecal occult 59 germline mutation 59 Non inferiority 59 polycythemia vera PV 59 pituitary adenomas 59 polycythemia vera essential thrombocythemia 59 antibody MAb 59 myeloperoxidase 59 diabetes mellitus DM 59 thrombocytosis 59 breast carcinoma 59 chemoresistant 59 Pelvic inflammatory 59 serum cortisol 59 artery stenosis 59 antigen PSA 59 aspartate aminotransferase 59 prostate abnormalities 59 trastuzumab Herceptin ® 59 Epstein Barr Virus EBV 59 VATS lobectomy 59 treat benign prostatic 59 myocardial necrosis 59 MGUS 59 cervical lesions 59 TNFalpha 59 methicillin susceptible Staphylococcus aureus 59 HPV genotypes 59 pretransplant 59 gamma glutamyl 59 Acute renal failure 59 neutropaenia 59 Oropharyngeal 59 HRCT 59 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 59 Cervista HPV HR 59 mg kg Hematide 59 COPEGUS therapy 59 Escherichia coli Klebsiella pneumoniae 59 hemorrhage necrosis 59 NRTI resistance 59 hemodynamically significant 59 splice variants 59 LV ejection fraction 59 HER2 positive cancers 59 hereditary hemochromatosis 59 underwent resection 59 kidney urologic 59 Angiotensin converting enzyme 59 mucosal lesions 59 Fludara ® 59 premalignant lesion 59 steroidogenesis 59 histologic findings 59 hemagglutination inhibition HAI 59 plasminogen activator inhibitor 59 Hypertrophic 59 cervical cytology 59 ABL1 59 prostatic 59 lactate dehydrogenase 59 Actinic Keratosis 59 Hodgkin lymphoma HL 59 carotid stenosis 59 TP# mutations 59 HAAH 59 methylation markers 59 Phacoemulsification 59 Cytomegalovirus CMV 59 torsade de pointes 59 malignant neoplasm 59 bronchoalveolar lavage BAL 59 androgen receptor AR 59 RASSF1A 59 clinically localized prostate 59 μg ml 59 ^ sup #m 59 artery embolization 59 lymphoproliferative disorders 59 â ‰ ¥ 59 cerebral angiography 59 bone scintigraphy 59 #F FDG PET 59 clinico pathological 59 arterial calcification 59 Retreatment 59 pCR 59 distant metastasis 59 unfavorable prognostic 59 abnormal p# 59 underwent surgical resection 59 CCyR 59 mutated K ras 59 assay detects 59 anthracycline taxane 59 follicular lymphoma FL 59 anastrazole 59 HER2 positivity 59 axillary node 59 pleurodesis 59 tissue oxygenation 59 cytomegalovirus infection 59 receptor tyrosine kinase inhibitor 59 osteoid osteoma 59 hyperplasia BPH 59 Solazed TM 59 IgA deficiency 59 follicle stimulating hormone FSH 59 secondary hyperparathyroidism 59 LymphoStat B belimumab 59 Polymorphisms 59 S aureus 59 esophagogastroduodenoscopy 59 ErbB2 positive 59 serologic testing 59 T SPOT.TB 59 malignant ascites 59 HIV1 59 Cytogenetic 59 cytoreduction 59 abdominal computed tomography 59 tumor xenograft models 59 Gram stain 59 biologic DMARD 59 serum TSH 59 amplified nucleic acid 59 COL#A# 59 vWF 59 HBeAg negative 59 pretest probability 59 HER-2/neu 59 radical retropubic prostatectomy 59 prostate adenocarcinoma 59 cardiac repolarization 59 nephrotoxicity 59 tumor infiltrating lymphocytes 59 NNRTI resistance 59 lung pancreatic 59 Epidermal Growth Factor Receptor 59 smoldering myeloma 59 biochemical recurrence 59 alanine aminotransferase 59 malignant ovarian 59 RT qPCR 59 pelvic lymph node dissection 59 bronchial hyperresponsiveness 59 Achieves Primary Endpoint 59 ertapenem 59 chromosomal mutations 59 alkaline phosphatase 59 osteogenic 59 NSCLC tumors 59 ELISA assays 59 CCR5 delta# 59 Allogeneic 59 RRM1 59 endometrial ovarian 59 Trichophyton rubrum 59 intraventricular 59 endoglin 59 MALT lymphoma 59 ALT normalization 59 BRCA2 carriers 59 phototoxicity 59 pyelonephritis 59 lichen planus 59 seminal vesicle 59 ventilation perfusion 59 mU liter 59 extramedullary 59 RhD 59 mediated inhibition 59 pretreatment serum 59 phosphoprotein 59 CP CPPS 59 Resection 59 Tumor Response 59 nasopharyngeal swabs 59 hemoglobin Hb 59 oncogenic HPV 59 steroidogenic 59 Infusion Reactions Severe 59 airway responsiveness 59 TT genotype 59 testicular germ cell 59 Virologic 59 Angiographic 59 1α 59 unfavorable cytogenetics 59 hydroxylase 59 hamartoma 59 sputum cytology 59 homozygotes 59 pregnancy bacterial vaginosis 59 bladder ovarian 59 HbF 59 ERBB2 59 Diffuse Large B 59 Main Outcome Measure 59 essential thrombocythemia ET 59 tumor histology 59 stage IIIb IV 59 RhuDex R 59 T1a 59 STAT3 signaling 59 liposomal amphotericin B 59 induced sputum 59 herpesviruses 58 Epratuzumab 58 Lymph node 58 varices 58 fasting plasma 58 GRNOPC1 contains 58 hyperoxaluria 58 paraneoplastic 58 operable breast cancer 58 HBeAg positive patients 58 Hematopoietic 58 multivariable Cox 58 Upregulation 58 prognostic biomarker 58 diagnostic biomarker 58 quantitative computed tomography 58 thyrotropin 58 colonoscopy sigmoidoscopy 58 NGAL 58 umbilical vein 58 thyroid stimulating hormone 58 CsA 58 HPV subtypes 58 Prostate Specific Antigen PSA 58 esophagogastric 58 radiographic findings 58 alpha1 58 Soft Tissue Sarcoma 58 sFlt 1 58 endocervical 58 cisplatin resistant 58 eosinophilia 58 ALT AST 58 Vascugel ® 58 choroidal neovascularization 58 Follicular Lymphoma 58 Ebstein anomaly 58 Multivariate analysis 58 variceal bleeding 58 N telopeptide 58 proteoglycan 58 intraoperative complications 58 renal tumors 58 hyperphenylalaninemia HPA due 58 Mantoux test 58 capillary leakage 58 neoplasms 58 Streptococcus agalactiae 58 LV dysfunction 58 pheochromocytoma 58 ductal cancer 58 cholestasis 58 neoplastic lesions 58 Subtype 58 System IPSS 58 E selectin 58 IFN ß 58 chronic GVHD 58 serum phosphate 58 helical CT 58 HBeAg seroconversion 58 hydronephrosis 58 EGFR HER2 58 microalbumin 58 lymphoid organs 58 postoperative morbidity 58 mediated apoptosis 58 Trichomonas vaginalis 58 NMP# 58 Monoclonal 58 germline mutations 58 isotypes 58 lipoprotein associated phospholipase 58 prospective multicenter study 58 TRAIL R1 58 glomerular filtration 58 pituitary hormone 58 Fas ligand 58 human leukocyte antigens 58 epididymal 58 Myocardial Perfusion Imaging 58 atypical ductal hyperplasia 58 Ultrasonography 58 alkaline phosphatase ALP 58 pancreatectomy 58 nonproliferative 58 malignant lesions 58 F FLT 58 Lymphoid 58 intratumoral 58 ovarian pancreatic 58 antithymocyte globulin 58 colonoscopic 58 Coronary angiography 58 sonographic findings 58 Orthostatic hypotension 58 IgG antibody 58 CIN3 + 58 TGF alpha 58 murine models 58 tumors GIST 58 fosbretabulin 58 Natalizumab 58 HMPV 58 anthracycline containing 58 LHRH antagonists 58 inconclusive Pap 58 vesicoureteral reflux 58 precancerous condition 58 unresectable tumors 58 Activating mutations 58 Fontan procedure 58 alanine aminotransferase ALT 58 perfusion MRI 58 culture supernatants 58 novel VDA molecule 58 thoracoscopic lobectomy 58 serum PTH 58 Subgroup analyzes 58 Onalta TM 58 lung biopsy 58 serum calcium levels 58 transaminases 58 μg liter 58 anovulatory 58 sonographically 58 Adaptive Radiation Therapy 58 immunocompetent 58 serum testosterone 58 fallopian tube cancers 58 prognostic indicator 58 prostanoid 58 Thromboembolic 58 lymphadenectomy 58 florbetaben 58 serum phosphorous 58 electrophysiologic 58 urine dipstick 58 sensory neuropathy 58 obstructive CAD 58 pulsed Doppler 58 murine leukemia 58 congenital adrenal hyperplasia CAH 58 chromosome #p# [002] 58 cytolytic activity 58 chemosensitivity 58 Ultrasensitive 58 TNF blocker therapy 58 hypogonadal 58 Doppler sonography 58 bronchogenic carcinoma 58 #beta 58 vWD 58 etiologic agent 58 Monocyte 58 recurrent bladder 58 Interferon gamma 58 depsipeptide 58 RAS mutations 58 serous ovarian cancer 58 APOE e4 58 aminotransferases 58 anogenital warts 58 DU# [002] 58 hyperhomocysteinemia 58 sero positive 58 QuantiFERON 58 coagulation abnormalities 58 intima media thickness 58 colon rectal 58 eosinophil count 58 β amyloid 58 troponins 58 hypervascular tumors 58 allogeneic stem cell 58 FISH fluorescence 58 Kaplan Meier analysis 58 posttransplant 58 erlotinib Tarceva ® 58 ERK1 2 58 invasive lobular 58 International Prognostic Scoring 58 recurrent ovarian 58 adjuvant radiotherapy 58 Tr DNA 58 humoral responses 58 excisional biopsy 58 conventional coronary angiography 58 percutaneous transluminal coronary angioplasty 58 MTHFR 58 pancreatic lung 58 Hypertriglyceridemia 58 neuritic 58 5alpha reductase 58 fast bacilli 58 Ectopic pregnancy 58 histone deacetylase HDAC inhibitor 58 Tasigna prolongs 58 EUS FNA 58 histologic 58 binds selectively 58 cardiac perfusion 58 RQ PCR 58 intracranial hemorrhage ICH 58 mIU ml 58 lymphadenopathy 58 carcinoids 58 endobronchial 58 fluoropyrimidine 58 intraobserver 58 renal pelvis 58 Pelvic Inflammatory Disease 58 HGD 58 epithelial ovarian 58 aggregometry 58 cerebral spinal 58 AGHD 58 Hypertrophy 58 antiretroviral naïve 58 chlamydial infection 58 adenoma recurrence 58 pulmonary resection 58 pharmacodynamic biomarkers 58 deCODE BreastCancer 58 polyposis 58 haematuria 58 multidetector row 58 mammographically 58 leukocytosis 58 deoxy 58 premalignant 58 colonography 58 Microalbuminuria 58 bronchial epithelial cells 58 hippocampal atrophy 58 Systemic Lupus Erythematosus SLE 58 radical cystectomy 58 ptau 58 NQO1 58 sonographic examination 58 hematuria 58 hepatic lesions 58 arterial thromboembolism 58 histopathologic 58 mL/min/#.# m 2 58 hypothalamic pituitary adrenal axis 58 aminotransferase ALT 58 colorectal neoplasms 58 parasitological 58 Epigenomics proprietary 58 MAGE A3 ASCI 58 1 antitrypsin AAT 58 autosomal recessive disorder 58 vulvovaginal candidiasis 58 conjunctival hyperemia 58 PNET 58 HCV antibodies 58 peritoneal cancer 58 BRCA mutation carriers 58 B7 H3 58 antinuclear antibodies